Entrada Therapeutics Inc. (TRDA)
8.79
0.03 (0.34%)
At close: Apr 02, 2025, 3:59 PM
9.15
4.04%
After-hours: Apr 02, 2025, 06:58 PM EDT
Entrada Therapeutics Revenue
Entrada Therapeutics reported an annual revenue of $210.78M, reflecting a 63.38% growth. For the quarter ending December 31, 2024, Entrada Therapeutics generated $37.4M in revenue.
Revenue (ttm)
$210.78M
Revenue Growth
63.38%
Price / Sales Ratio
3.06
Revenue / Employee
$1.15M
Employees
183
Market Cap
330.64M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 210.78M | +63.38% |
| Dec 31, 2023 | 129.01M | +Infinity% |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |